Free Trial

Envestnet Asset Management Inc. Has $49.30 Million Stake in Chemed Corporation (NYSE:CHE)

Chemed logo with Medical background

Envestnet Asset Management Inc. grew its position in Chemed Corporation (NYSE:CHE - Free Report) by 4.8% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 80,123 shares of the company's stock after purchasing an additional 3,695 shares during the period. Envestnet Asset Management Inc. owned about 0.55% of Chemed worth $49,302,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Atala Financial Inc bought a new position in shares of Chemed in the fourth quarter valued at about $29,000. Alpine Bank Wealth Management bought a new position in shares of Chemed in the first quarter valued at about $29,000. CBIZ Investment Advisory Services LLC raised its holdings in shares of Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after buying an additional 22 shares during the last quarter. HM Payson & Co. bought a new position in shares of Chemed in the first quarter valued at about $30,000. Finally, Whipplewood Advisors LLC raised its holdings in shares of Chemed by 54.5% in the first quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after buying an additional 18 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Trading Down 1.3%

Shares of CHE stock traded down $5.99 on Friday, reaching $459.69. The company had a trading volume of 95,700 shares, compared to its average volume of 112,308. The stock has a market cap of $6.73 billion, a PE ratio of 22.39, a PEG ratio of 2.21 and a beta of 0.50. The company has a 50-day moving average of $544.66 and a 200-day moving average of $560.96. Chemed Corporation has a 12 month low of $457.44 and a 12 month high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. The business had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. Chemed had a return on equity of 27.58% and a net margin of 12.40%. Chemed's revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period in the prior year, the business earned $5.20 EPS. Sell-side analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th were issued a $0.50 dividend. The ex-dividend date was Thursday, May 29th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.44%. Chemed's dividend payout ratio (DPR) is presently 9.74%.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 1,500 shares of Chemed stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $576.45, for a total value of $864,675.00. Following the sale, the chief executive officer directly owned 101,197 shares in the company, valued at $58,335,010.65. This trade represents a 1.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Spencer S. Lee sold 1,500 shares of Chemed stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of $577.99, for a total transaction of $866,985.00. Following the completion of the sale, the executive vice president owned 14,627 shares in the company, valued at $8,454,259.73. This trade represents a 9.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,500 shares of company stock worth $2,598,450 over the last quarter. 3.29% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CHE. Bank of America dropped their price objective on Chemed from $708.00 to $650.00 and set a "buy" rating for the company in a report on Monday, June 30th. Wall Street Zen cut Chemed from a "buy" rating to a "hold" rating in a research note on Saturday, July 5th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $640.00 price target (down from $674.00) on shares of Chemed in a research note on Monday, June 30th.

Read Our Latest Report on CHE

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines